Properties
What is it?
Name - Synovial HL Hybrid 64mg/2ml #1 Indications Synovial HL-Hybrid, with its unique formulation, belongs to the latest generation of intra-articular therapeutic agents. Synovial HL-Hybrid is a medical device designed for the integration of synovial fluid. It allows for the restoration of physiological and rheological properties of osteoarthritic joints. Synovial HL-Hybrid reduces joint pain and helps restore joint mobility. Clinical data has shown that the use of Synovial HL-Hybrid in conjunction with laser therapy can improve symptoms associated with tendinopathy. Synovial HL-Hybrid is indicated for acute and chronic degenerative lesions (e.g., osteoarthritis), pain, or reduced mobility in large and small joints, and in cases of post-traumatic disorders. Synovial HL-Hybrid reduces pain and restores the movement of joints and tendons. Synovial HL-Hybrid is indicated for adults of both sexes. It should only be administered by qualified personnel via intra-articular injection. Dosage It is recommended to administer 1 injection per week, a maximum of 3, within the treatment cycle before infiltration. The advisability and frequency of repeating the treatment cycle should be assessed by a doctor, taking into account the risk/benefit ratio for each individual patient in any case. Side Effects Intra-articular infiltration of Synovial HL-Hybrid may cause local adverse effects. When using Synovial, symptoms such as pain, a sensation of heat, redness, or swelling may occur at the injection site. These secondary manifestations can be alleviated by applying ice to the treated area. The phenomena usually disappear after a short period. The patient must inform the doctor about any adverse effects that occur during treatment. In case of an incident, inform the manufacturer or the competent authority.